Archford Capital Strategies’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.52M | Sell |
27,354
-6,991
| -20% | -$818K | 0.36% | 69 |
|
|
2026
Q1 | $4.13M | Buy |
34,345
+22,076
| +180% | +$2.55M | 0.47% | 54 |
|
|
2025
Q4 | $1.29M | Sell |
12,269
-92
| -0.7% | -$8.64K | 0.15% | 135 |
|
|
2025
Q3 | $1.04M | Sell |
12,361
-73
| -0.6% | -$6.01K | 0.12% | 159 |
|
|
2025
Q2 | $984K | Buy |
12,434
+43
| +0.3% | +$3.42K | 0.13% | 151 |
|
|
2025
Q1 | $1.11M | Buy |
12,391
+42
| +0.3% | +$3.92K | 0.16% | 135 |
|
|
2024
Q4 | $1.23M | Sell |
12,349
-243
| -2% | -$25.1K | 0.19% | 124 |
|
|
2024
Q3 | $1.38M | Buy |
12,592
+421
| +3% | +$50K | 0.21% | 110 |
|
|
2024
Q2 | $1.51M | Sell |
12,171
-182
| -1% | -$23.4K | 0.24% | 98 |
|
|
2024
Q1 | $1.63M | Buy |
12,353
+104
| +0.8% | +$12.8K | 0.27% | 96 |
|
|
2023
Q4 | $1.34M | Buy |
12,249
+738
| +6% | +$76.6K | 0.24% | 107 |
|
|
2023
Q3 | $1.19M | Buy |
11,511
+2,234
| +24% | +$241K | 0.24% | 104 |
|
|
2023
Q2 | $1.01M | Buy |
9,277
+2,091
| +29% | +$237K | 0.19% | 126 |
|
|
2023
Q1 | $804K | Buy |
7,186
+1,048
| +17% | +$113K | 0.17% | 139 |
|
|
2022
Q4 | $681K | Buy |
6,138
+159
| +3% | +$16.3K | 0.16% | 157 |
|
|
2022
Q3 | $515K | Buy |
5,979
+201
| +3% | +$17.9K | 0.13% | 176 |
|
|
2022
Q2 | $527K | Sell |
5,778
-391
| -6% | -$34.7K | 0.13% | 173 |
|
|
2022
Q1 | $516K | Buy |
6,169
+1,419
| +30% | +$112K | 0.12% | 179 |
|
|
2021
Q4 | $364K | Buy |
4,750
+1,269
| +36% | +$101K | 0.08% | 221 |
|
|
2021
Q3 | $261K | Sell |
3,481
-517
| -13% | -$39.3K | 0.06% | 272 |
|
|
2021
Q2 | $311K | Sell |
3,998
-2,567
| -39% | -$191K | 0.08% | 233 |
|
|
2021
Q1 | $480K | Buy |
6,565
+255
| +4% | +$18.8K | 0.13% | 178 |
|
|
2020
Q4 | $500K | Sell |
6,310
-112
| -2% | -$8.57K | 0.12% | 184 |
|
|
2020
Q3 | $508K | Sell |
6,422
-363
| -5% | -$28.4K | 0.14% | 169 |
|
|
2020
Q2 | $501K | Sell |
6,785
-283
| -4% | -$21.3K | 0.15% | 154 |
|
|
2020
Q1 | $519K | Sell |
7,068
-1,846
| -21% | -$145K | 0.2% | 143 |
|
|
2019
Q4 | $774K | Sell |
8,914
-1,751
| -16% | -$144K | 0.27% | 118 |
|
|
2019
Q3 | $857K | Buy |
10,665
+2,044
| +24% | +$164K | 0.32% | 97 |
|
|
2019
Q2 | $690K | Sell |
8,621
-130
| -1% | -$9.95K | 0.25% | 116 |
|
|
2019
Q1 | $694K | Sell |
8,751
-656
| -7% | -$49.1K | 0.26% | 118 |
|
|
2018
Q4 | $686K | Buy |
9,407
+518
| +6% | +$36.6K | 0.28% | 110 |
|
|
2018
Q3 | $602K | Buy |
8,889
+392
| +5% | +$25K | 0.22% | 130 |
|
|
2018
Q2 | $492K | Buy |
8,497
+5,875
| +224% | +$331K | 0.17% | 154 |
|
|
2018
Q1 | $142K | Buy |
+2,622
| New | +$142K | 0.06% | 138 |
|
|
2017
Q4 | – | Sell |
-4,168
| Closed | -$255K | – | 195 |
|
|
2017
Q3 | $255K | Buy |
4,168
+1
| +0% | +$61 | 0.1% | 177 |
|
|
2017
Q2 | $255K | Sell |
4,167
-106
| -2% | -$6.45K | 0.1% | 169 |
|
|
2017
Q1 | $259K | Hold |
4,273
| – | – | 0.1% | 178 |
|
|
2016
Q4 | $240K | Hold |
4,273
| – | – | 0.1% | 162 |
|
|
2016
Q3 | $254K | Sell |
4,273
-262
| -6% | -$15.3K | 0.1% | 165 |
|
|
2016
Q2 | $249K | Buy |
4,535
+498
| +12% | +$26.5K | 0.13% | 138 |
|
|
2016
Q1 | $204K | Buy |
4,037
+188
| +5% | +$9.21K | 0.1% | 164 |
|
|
2015
Q4 | $194K | Buy |
3,849
+1,311
| +52% | +$66.1K | 0.09% | 169 |
|
|
2015
Q3 | $120K | Buy |
2,538
+1
| +0% | +$53 | 0.09% | 139 |
|
|
2015
Q2 | $138K | Hold |
2,537
| – | – | 0.1% | 132 |
|
|
2015
Q1 | $139K | Buy |
2,537
+1,049
| +70% | +$59.4K | 0.1% | 133 |
|
|
2014
Q4 | $81K | Hold |
1,488
| – | – | 0.06% | 166 |
|
|
2014
Q3 | $84K | Buy |
1,488
+1
| +0.1% | +$56 | 0.07% | 164 |
|
|
2014
Q2 | $82.1K | Sell |
1,487
-285
| -16% | -$15.5K | 0.06% | 167 |
|
|
2014
Q1 | $96K | Buy |
+1,772
| New | +$91.8K | 0.08% | 161 |
|
Other funds holding MRK
ATO
QP
AAMU
Archford Capital Strategies's MRK Position: Q2 2026 in Review
Archford Capital Strategies reduced its Merck (MRK) stake by 20% in Q2 2026, selling an estimated $818K and leaving 27,354 shares worth $3.52M. The position accounts for 0.36% of the portfolio, ranked #69.
Archford Capital Strategies first reported a position in MRK in Q1 2014 and has held it in 49 quarters since. The position peaked at $4.13M in Q1 2026. 1,411 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Archford Capital Strategies held 27,354 shares of Merck worth $3.52M as of Q2 2026.
- Archford Capital Strategies sold 6,991 Merck shares in Q2 2026, an estimated $818K.
- Merck made up 0.36% of Archford Capital Strategies's portfolio in Q2 2026, its #69 holding.
- Archford Capital Strategies first reported a position in Merck in Q1 2014 and has held it in 49 quarters since.
- Archford Capital Strategies's Merck position peaked at $4.13M in Q1 2026.
- 1,411 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.